Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : SRNE source : Www.prnewswire.com save search
Global CAR T-Cell Therapy Market Analysis Report 2023: Drug type, Indication, Target Antigen, End-user and Region - Forecast to 2030
Published: 2024-01-24 (Crawled : 17:00) - prnewswire.com
PFE A | $25.39 -0.12% -0.12% 36M
|
Health Technology
|
| O: 0.39%
H: 0.82%
C: -0.74%
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 0.22%
H: 0.43%
C: -0.39%
SRNE | $0.028 -8.85% 42K
|
Health Technology
|
| O: -63.33%
H: 263.64%
C: 127.27%
GILD | News | $66.16 -1.15% -1.16% 6.4M
|
Health Technology
|
| O: 0.1%
H: 0.43%
C: -0.04%
AUTL | $4.8 -0.83% -0.83% 1.2M
|
Health Technology
|
| O: -0.91%
H: 11.52%
C: 4.94%
drug report t-cell global therapy market
Sorrento Announces Launch of Voluntary Offering to Dividend Short Holders with Deadline to Participate by July 31, 2023
Published: 2023-07-21 (Crawled : 22:00) - prnewswire.com
SCLX | $0.8942 -23.57% -30.84% 2.8M
|
| Email alert
Add to watchlist
SRNE | $0.028 -8.85% 42K
|
Health Technology
| Email alert
Add to watchlist
deadline offering
Antibody Drug Conjugate - Competitive Landscape 2023 Study: Featuring Coverage on 180+ Companies and 300+ Drugs
Published: 2023-06-30 (Crawled : 18:00) - prnewswire.com
SRNE | $0.028 -8.85% 42K
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
| Email alert
Add to watchlist
IMGN | $31.23 0.03% 49M
|
Health Technology
| Email alert
Add to watchlist
FNCTF | News | $11.0354 -20.84% 34K
|
Communications
| Email alert
Add to watchlist
drug companies antibody
Antibody-drug Conjugates Clinical Trial Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 180+ Companies Working in the Domain
Published: 2023-06-26 (Crawled : 21:00) - prnewswire.com
LLY | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: 2.15%
H: 1.18%
C: 0.43%
SRNE | $0.028 -8.85% 42K
|
Health Technology
|
| O: -1.0%
H: 4.2%
C: 1.3%
SGEN | $228.74 0.1% 20M
|
Health Technology
|
| O: 0.82%
H: 0.02%
C: -0.85%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 0.17%
H: 0.0%
C: 0.0%
OMER | $3.22 -3.59% -3.73% 430K
|
Health Technology
|
| O: 0.19%
H: 2.22%
C: 1.76%
IMGN | $31.23 0.03% 49M
|
Health Technology
|
| O: 0.58%
H: 2.57%
C: 0.26%
companies pipeline trial
Sorrento Therapeutics, Inc.'s Bankruptcy Court Orders Brokerage Firms to Credit Dividended Scilex Stock to Customers' Accounts and Sorrento Advises Holders of Dividended Scilex Stock to Contact Brokerage Firms to Deliver the Stock to Individual Accounts
Published: 2023-05-14 (Crawled : 20:20) - prnewswire.com
SCLX | $0.8942 -23.57% -30.84% 2.8M
|
|
| O: 1.29%
H: 48.72%
C: 21.35%
SRNE | $0.028 -8.85% 42K
|
Health Technology
|
| O: 3.3%
H: 26.37%
C: 14.45%
Sorrento Therapeutics, Inc.'s Bankruptcy Court Extends the Lockup Period on Shares of Scilex Stock Distributed by Sorrento to its Stockholders as a Dividend
Published: 2023-04-25 (Crawled : 00:00) - prnewswire.com
SCLX | $0.8942 -23.57% -30.84% 2.8M
|
|
| O: 3.24%
H: 12.41%
C: 7.56%
SRNE | $0.028 -8.85% 42K
|
Health Technology
|
| O: 1.64%
H: 9.68%
C: 7.16%
Antibody-drug Conjugates Market is Predicted to Exhibit Remarkable Growth by 2032, Analyzes DelveInsight
Published: 2023-04-10 (Crawled : 15:00) - prnewswire.com
STRO M | $3.76 -1.05% -1.06% 770K
|
Health Technology
|
| O: -0.87%
H: 0.0%
C: -5.05%
SRNE | $0.028 -8.85% 42K
|
Health Technology
|
| O: -1.32%
H: 1.34%
C: -2.33%
INCY | $52.82 0.19% 0.19% 1.8M
|
Health Technology
|
| O: -2.69%
H: 1.6%
C: 0.61%
IMGN | $31.23 0.03% 49M
|
Health Technology
|
| O: 0.0%
H: 0.99%
C: -4.93%
CLLS | $2.48 0.81% 0.4% 15K
|
Health Technology
|
| O: 1.02%
H: 0.0%
C: -1.51%
growth market
Sorrento Therapeutics, Inc.'s Bankruptcy Court Requires Brokerages to Provide Information Related to Scilex Common Stock
Published: 2023-04-04 (Crawled : 18:00) - prnewswire.com
SCLX | $0.8942 -23.57% -30.84% 2.8M
|
|
| O: 0.86%
H: 0.0%
C: -3.65%
BR | $192.98 -0.24% -0.51% 390K
|
Commercial Services
|
| O: 0.3%
H: 0.51%
C: -1.45%
SRNE | $0.028 -8.85% 42K
|
Health Technology
|
| O: 2.77%
H: 0.0%
C: -7.47%
Sorrento Therapeutics, Inc. Receives Final Court Approval for $75 Million Debtor-In-Possession Financing
Published: 2023-03-29 (Crawled : 18:00) - prnewswire.com
MC | $50.97 -0.57% 0.0% 370K
|
Finance
|
| O: 1.57%
H: 0.05%
C: -1.6%
SRNE | $0.028 -8.85% 42K
|
Health Technology
|
| O: -1.47%
H: 7.1%
C: 4.48%
approval
Court Confirms Sorrento Therapeutics, Inc.'s $125 Million Arbitration Award Against NantPharma, LLC
Published: 2023-03-17 (Crawled : 15:00) - prnewswire.com
SRNE | $0.028 -8.85% 42K
|
Health Technology
|
| O: -0.96%
H: 29.96%
C: 17.63%
award
Sorrento Therapeutics, Inc. Receives Court Approval for $75 Million Financing in Chapter 11 Case
Published: 2023-02-21 (Crawled : 00:00) - prnewswire.com
SCLX | $0.8942 -23.57% -30.84% 2.8M
|
|
| O: -1.9%
H: 5.12%
C: 3.74%
SRNE | $0.028 -8.85% 42K
|
Health Technology
|
| O: 11.57%
H: 10.12%
C: -28.53%
approval
Sciatica Treatment Market to Reach USD 991.3 Million, Globally, by 2031 at 3.9% CAGR: Allied Market Research
Published: 2023-02-15 (Crawled : 16:00) - prnewswire.com
TEVA | $12.78 -3.03% -0.24% 9M
|
Health Technology
|
| O: -0.98%
H: 1.58%
C: 1.58%
SRNE | $0.028 -8.85% 42K
|
Health Technology
|
| O: 1.27%
H: 2.75%
C: -17.4%
treatment research market
Caris Life Sciences, Prostate Cancer Clinical Trial Consortium and Sorrento Therapeutics Announce Collaboration to Advance Precision Medicine Development Using Comprehensive Genomic Profiling
Published: 2022-06-02 (Crawled : 11:00) - prnewswire.com
SRNE | $0.028 -8.85% 42K
|
Health Technology
|
| O: -5.64%
H: 0.0%
C: 0.0%
collaboration genomic trial therapeutics cancer prostate cancer
The Worldwide Cancer Pain Industry is Expected to Reach $9.9 Billion by 2030
Published: 2022-03-09 (Crawled : 17:00) - prnewswire.com
TEVA | $12.78 -3.03% -0.24% 9M
|
Health Technology
|
| O: 2.57%
H: 4.49%
C: 3.17%
SRNE | $0.028 -8.85% 42K
|
Health Technology
|
| O: 2.4%
H: 10.33%
C: 8.45%
cancer
Immuno-oncology Cell Therapy Market worth $34.69 Billion by 2030 - Exclusive Report by InsightAce Analytic
Published: 2022-03-03 (Crawled : 10:00) - prnewswire.com
SRNE | $0.028 -8.85% 42K
|
Health Technology
|
| O: -1.01%
H: 0.41%
C: -6.56%
BGNE | $131.94 0.06% 0.06% 130K
|
Health Technology
|
| O: -0.13%
H: 0.0%
C: -13.26%
cel report therapy
Outlook on the CAR T-cell Therapy Global Market to 2031 - by Product Type, Indications, End-user and Region
Published: 2022-01-14 (Crawled : 14:00) - prnewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 1.26%
H: 0.0%
C: 0.0%
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 0.02%
H: 0.0%
C: 0.0%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -0.53%
H: 0.0%
C: 0.0%
SRNE | $0.028 -8.85% 42K
|
Health Technology
|
| O: -5.96%
H: 0.0%
C: 0.0%
GILD | News | $66.16 -1.15% -1.16% 6.4M
|
Health Technology
|
| O: -0.32%
H: 0.0%
C: 0.0%
BLUE | $0.9583 -0.52% -0.52% 6.5M
|
Health Technology
|
| O: -0.57%
H: 0.0%
C: 0.0%
cel therapy t-cell
WuXi Biologics and ImmuneOncia Sign MOU for Development and Manufacturing of Anti-PD-L1/CD47 Bispecific Antibody
Published: 2021-12-28 (Crawled : 01:00) - prnewswire.com
SRNE | $0.028 -8.85% 42K
|
Health Technology
|
| O: -1.26%
H: 1.45%
C: -10.73%
cd47 antibody
Anxious World Waits As Covid Vaccine Makers Address Omicron Variant
Published: 2021-12-07 (Crawled : 14:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: 5.22%
H: 0.0%
C: -1.25%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 2.13%
H: 0.0%
C: 0.0%
GSK | $39.27 -0.83% 0.01% 2.2M
|
Health Technology
|
| O: 0.14%
H: 0.0%
C: 0.0%
VIR | $7.96 -3.52% -3.64% 880K
|
Health Technology
|
| O: -6.42%
H: 8.6%
C: 8.45%
SRNE | $0.028 -8.85% 42K
|
Health Technology
|
| O: 6.57%
H: 14.77%
C: 11.21%
RDHL | $0.4301 11.57% 10.37% 660K
|
Health Technology
|
| O: 0.37%
H: 10.37%
C: 9.63%
covid vaccine
Increasing Adoption of Targeted Cancer Therapies to Propel Oncolytic Virus Immunotherapy Market, Says TMR
Published: 2021-08-03 (Crawled : 13:15) - prnewswire.com
SRNE | $0.028 -8.85% 42K
|
Health Technology
|
| O: -0.48%
H: 0.72%
C: -1.33%
REPL | $6.98 -3.19% -3.3% 1.1M
|
Health Technology
|
| O: 0.84%
H: 3.45%
C: 1.78%
ONCR | $0.126 -75.95% 140K
|
Health Technology
|
| O: -0.24%
H: 1.98%
C: -1.74%
immunotherapy therapy cancer
Delta Variant Infections of COVID Rising Quickly & Now Responsible for 83% of All U.S. Cases
Published: 2021-07-22 (Crawled : 14:00) - prnewswire.com
TAK | News | $13.16 0.08% 0.0% 1.3M
|
Health Technology
|
| O: 0.3%
H: 0.24%
C: -0.53%
PFE A | $25.39 -0.12% -0.12% 36M
|
Health Technology
|
| O: 0.24%
H: 1.05%
C: 0.85%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -0.08%
H: 1.01%
C: 0.37%
SRNE | $0.028 -8.85% 42K
|
Health Technology
|
| O: -1.22%
H: 1.91%
C: -1.35%
MRNA S | $102.015 -1.38% -1.4% 1.7M
|
Health Technology
|
| O: -0.66%
H: 3.32%
C: 1.4%
BNTX | $86.19 -0.24% -0.24% 580K
|
Health Technology
|
| O: 3.83%
H: 5.33%
C: 4.24%
covid injection response infections
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.